CRESCENT BIOPHARMA, INC. - CBIO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A TANG CAPITAL MANAGEMENT, LLC 4.21% 1,160,000 View
May 15, 2026 SCHEDULE 13G/A KEVIN TANG 4.21% 1,160,000 View
May 15, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS, LP 2.24% 616,477 View
May 15, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS INTERNATIONAL, LP 1.64% 451,619 View
May 15, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS III, INC 0.33% 91,904 View
May 15, 2026 SCHEDULE 13G/A TANG CAPITAL PARTNERS IV, INC 0.0% 0 View
May 15, 2026 SCHEDULE 13G Balyasny Asset Management L.P. 5.48% 1,510,033 View
May 15, 2026 SCHEDULE 13G BAM GP LLC 5.48% 1,510,033 View
May 15, 2026 SCHEDULE 13G Balyasny Asset Management Holdings LP 5.48% 1,510,033 View
May 15, 2026 SCHEDULE 13G Dames GP LLC 5.48% 1,510,033 View
May 15, 2026 SCHEDULE 13G Dmitry Balyasny 5.48% 1,510,033 View
Feb 17, 2026 SCHEDULE 13G Vestal Point Capital, LP 5.4% 1,500,000 View
Feb 17, 2026 SCHEDULE 13G Ryan Wilder 5.4% 1,500,000 View
Feb 17, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners III, L.P. 9.5% 2,666,064 View
Feb 17, 2026 SCHEDULE 13G/A VHCP Co-Investment Holdings III, LLC 9.5% 2,666,064 View
Feb 17, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners EG, L.P. 9.5% 2,666,064 View
Feb 17, 2026 SCHEDULE 13G/A VHCP Management III, LLC 9.5% 2,666,064 View
Feb 17, 2026 SCHEDULE 13G/A VHCP Management EG, LLC 9.5% 2,666,064 View
Feb 17, 2026 SCHEDULE 13G/A Nimish Shah 9.5% 2,666,064 View
Feb 17, 2026 SCHEDULE 13G/A Bong Y. Koh 9.5% 2,666,064 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 15.0% 4,133,514 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 15.0% 4,133,514 View
Dec 11, 2025 SCHEDULE 13G ForGrowth III PA B.V. 6.1% 1,677,852 View
Dec 11, 2025 SCHEDULE 13G Forbion Growth Opportunities Fund III Cooperatief U.A. 6.1% 1,677,852 View
Dec 11, 2025 SCHEDULE 13G Forbion Growth III Management B.V. 6.1% 1,677,852 View
Dec 08, 2025 SCHEDULE 13D/A — 19.99% — View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.